Trade Calls noted that Sophiris Bio Inc. (Nasdaq: SPHS) outperformed the S&P 500 by 120.58% over the past month. Shares of the biopharmaceutical soared $1.57 to close at $5.95.
Sophiris Bio outperforms S&P 500
July 25, 2016 at 18:22 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.